Castle Biosciences' Inventory Average rose 1666.78% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 1666.78%. This contributed to the annual value of $8.0 million for FY2024, which is 3485.15% up from last year.
Per Castle Biosciences' latest filing, its Inventory Average stood at $8.5 million for Q3 2025, which was up 1666.78% from $7.6 million recorded in Q2 2025.
Castle Biosciences' Inventory Average's 5-year high stood at $8.5 million during Q3 2025, with a 5-year trough of $2.2 million in Q1 2022.
Its 5-year average for Inventory Average is $5.1 million, with a median of $5.3 million in 2023.
Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 9446.35% in 2023, then plummeted by 386.86% in 2025.
Castle Biosciences' Inventory Average (Quarter) stood at $2.2 million in 2021, then surged by 77.02% to $3.9 million in 2022, then soared by 76.19% to $6.9 million in 2023, then increased by 7.26% to $7.4 million in 2024, then increased by 15.7% to $8.5 million in 2025.
Its Inventory Average stands at $8.5 million for Q3 2025, versus $7.6 million for Q2 2025 and $7.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value